Mass spectrometry identifies biologically active substances in blood plasma that distinguish hepatitis E patients from healthy controls.
Through the use of mass spectrometry, researchers from New Delhi, India, have identified biologically active substances in blood plasma that distinguish hepatitis E patients from healthy controls.
The team, led by Shikha Taneja of the International Centre for Genetic Engineering and Biotechnology (New Delhi, India), identified a number of biologically active substances associated with immune response that were expressed differently between the patients and controls. By enriching the peptidome fraction of the subjects’ plasma with mass spectrometry, the team compared the plasma peptides in both groups and discovered that those with the disease possessed distinguishing biomarkers. The team believes that the discovery of these biomarkers will assist in understanding disease pathogenesis and facilitate clinical management.
According to the World Health Organization, hepatitis E occurs when contaminated drinking water or food supplies are consumed, and is predominantly found in resource-poor regions. Hepatitis E is an acute, self-limiting condition that typically clears up on its own. However, severe cases of the disease can result in fulminant hepatic failure, which has a high mortality rate, particularly in pregnant women.
The findings were published in the February 4, 2011, issue of the journal Proteome Science.
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.